Ritedose is helping shape a new era of innovation in South Carolina, where life sciences companies are scaling faster than ever before.
South Carolina’s Life Sciences Momentum: Ritedose Helps Fuel a Fast-Growing Innovation Hub
South Carolina’s life-sciences industry is rapidly expanding. The state’s biotech ecosystem is booming, fueled by partnerships and bold investment. Once a quiet player, South Carolina is emerging as a powerhouse in life sciences, and Ritedose is a pivotal player driving the momentum.
Why Ritedose Chose South Carolina
Thirty years ago, a German Blow-Fill-Seal (BFS) manufacturer explored expanding its operations to California and ultimately landed in South Carolina. The decisive factor? According to Ritedose CEO Jody Chastain, the Port of Charleston and South Carolina’s central location not only changed the original plan, it laid the foundation for the state’s growing life sciences sector.
Ritedose Featured in GEN: A Case Study in Strategic Growth
As highlighted in a recent article by Genetic Engineering & Biotechnology News (GEN), Ritedose, a Columbia-based contract development and manufacturing organization (CDMO), is at the center of this momentum. Ritedose’s own transformation provided a case study in how strategic investment, innovation, and collaboration can fuel South Carolina’s shift into a national life science hub.
South Carolina’s Life Sciences Ecosystem Is Rapidly Expanding
As the collaborative, unifying leader of the state’s life sciences ecosystem, SCBio positions South Carolina as a top-tier home for biotechnology, medical research and innovation. Their Life + Science campaign further invites companies to “Build the life – and the science – that propels the future.” Regional economic development partners (like the Columbia Area Development Partnership) and the state itself (via the S.C. Department of Commerce Life Sciences) further have named life sciences as a top-tier priority, and the momentum has only grown.
Ritedose’s Role in South Carolina Life Sciences Growth
Ritedose has evolved from a manufacturer specializing in sterile Blow-Fill-Seal (BFS) technology equipment to a contract manufacturer and pharmaceutical company. Over the past few years, it has expanded its workforce and invested $17 million to strengthen lab capabilities — growing from around 400 to 600 employees and expanding its facilities ten-fold.
Ritedose’s growth is more than one company’s success story; it is a signal of the opportunity for innovation, supported by strategy, investment, and extraordinary employees. As organizations like Ritedose continue to scale, they are shaping their future and with it, the future of South Carolina. And if Ritedose is any indication, the future of the Palmetto State’s life sciences sector looks bright.
Read more:
Massachusetts Partnership Pays Off For South Carolina
From Columbia to the World: Ritedose Redefines Aseptic Manufacturing
